Sustained low‐density lipoprotein‐cholesterol <70 mg/dl is associated with improved cardiovascular outcomes in the clinical setting

Background and aims Clinical trials have shown that intensive low‐density lipoprotein cholesterol (LDL‐C) lowering improves cardiovascular outcomes among patients with atherosclerotic cardiovascular disease (ASCVD), but data are limited in real clinical practice, particularly for patients with ASCVD...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of clinical investigation 2022-05, Vol.52 (5), p.e13732-n/a
Hauptverfasser:	Sánchez‐Bacaicoa, Carmen, Galán, Javier, Guijarro, Carlos, Rico‐Martín, Sergio, Monreal, Manuel, Calderón‐García, Julián F., Aguilar‐Cortés, Eduardo, Sánchez Muñoz‐Torrero, Juan F., Alcalá‐Pedrajas, JN, Alvarez, LR, Arnedo, G, Coll, R, García‐Díaz, A, López‐Jiménez, L, Pascual, MT, Sahuquillo, JC, Sanclemente, C, Suriñach, JM, Toril, J, Yeste, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Arteriosclerosis Atherosclerosis Atherosclerosis - drug therapy Cardiovascular diseases Cardiovascular Diseases - drug therapy Cardiovascular Diseases - epidemiology Cholesterol Cholesterol, LDL Clinical medicine Clinical trials Confidence intervals Density Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use LDL Cholesterol Low density lipoprotein mortality outcomes Patients recurrent ischaemic event Reduction Risk Factors Stroke - epidemiology symptomatic artery disease Vascular diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!